Image For Activity Cover
ITLPEDUC2308 - CME/CMLE - Inside the Lab: Emerging Biomarkers in the Assessment of Alzheimer’s Disease
Course Description

Inside the Lab: Emerging Biomarkers in the Assessment of Alzheimer’s Disease
 
This podcast is designed to introduce pathologists, laboratory managers/directors, and laboratory professionals to emerging research in biomarker testing (cerebral spinal fluid [CSF] and blood-based biomarkers) and imaging for the detection of Alzheimer’s disease. You will learn about the biological significance and the clinical implications of these biomarkers, as well as how to utilize the AT(N) framework for Alzheimer’s disease diagnosis and biomarker classification. Additionally, you will also learn about the limitations of current biomarkers for Alzheimer’s disease and directions for future research.

Faculty/Authors
S.-H. Jerry Wang, MD, PhD
Assistant Professor of Pathology and Neurology
Duke/UNC ADRC Neuropathology Core Leader
Director, Duke Bryan Brain Bank
Associate Director, Autopsy Neuropathology
Duke University Medical Center

Target Audience
This podcast has been designed to meet the educational needs of pathologists, laboratory managers/directors, and laboratory professionals.

Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.

CME/CMLE Credit: 0.75
Estimated Completion Time: 0.75 hour
Format: Online Educational Activity

Physician Competencies: Patient Care, Medical Knowledge

Accreditation Statement:
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASCP designates this activity for a maximum of .75 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.
 
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time

Commercial Support
This activity is funded by an independent educational grant from Lilly.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Review the Faculty Disclosures.
  3. Click Go to Course to view an overview of the modules in this course.
  4. Click Access to begin the course.
  5. Review the Educational Activity.
  6. Submit the course Evaluation.
  7. Enter the maximum number of credits offered and click Claim CME to register credit.

Faculty Disclosure

Technical Considerations

Release Date: 11/30/2023
Review Date:
Expiration Date: 11/30/2026

Course Objectives
Following completion of this activity, you will be able to:
  • Discuss advances in body fluid biomarkers and imaging for Alzheimer’s disease, including the biological underpinnings of these biomarkers, clinical implications, limitations, and potential future research and trends

  • Utilize the AT(N) framework to classify biomarkers for Alzheimer’s disease

Summary
Availability: On-Demand
Credit Offered:
0.75 CME/CMLE Credit
Powered By